- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Clarification
In an article entitled “New PET crystal promises faster scans, better images” (SCAN 10/13/04), we identified a problem in the manufacture of a promising new PET crystal, called the BrilLanCe 380. We stated that “a few bugs in its manufacture still have to be worked out. The biggest is a tendency for the crystal to break.” The developer and manufacturer of this crystal, Saint Gobain Crystals, wishes to emphasize that once encapsulated in a finished detector, there is no problem or issue regarding “breakage” of the BrilLanCe crystal and that the finished detectors are mechanically robust.
In an article entitled "New PET crystal promises faster scans, better images" (SCAN 10/13/04), we identified a problem in the manufacture of a promising new PET crystal, called the BrilLanCe 380. We stated that "a few bugs in its manufacture still have to be worked out. The biggest is a tendency for the crystal to break." The developer and manufacturer of this crystal, Saint Gobain Crystals, wishes to emphasize that once encapsulated in a finished detector, there is no problem or issue regarding "breakage" of the BrilLanCe crystal and that the finished detectors are mechanically robust.
FDA Approves Fluorescence Imaging System for Detecting Residual Breast Cancer
April 18th 2024The combination of the optical imaging agent Lumisight and the fluorescence imaging device Lumicell Direct Visualization System, collectively known as LumiSystem, reportedly offers 84 percent accuracy with real-time detection of residual breast cancer after lumpectomy procedures.
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.
Could a Deep Learning Model for Mammography Improve Prediction of DCIS and Invasive Breast Cancer?
April 15th 2024Artificial intelligence (AI) assessment of mammography images may significantly enhance the prediction of invasive breast cancer and ductal carcinoma in situ (DCIS) in women with breast cancer, according to new research presented at the Society for Breast Imaging (SBI) conference.
